CN110946227A - 一种安眠饮料及其制备方法 - Google Patents
一种安眠饮料及其制备方法 Download PDFInfo
- Publication number
- CN110946227A CN110946227A CN201911349670.3A CN201911349670A CN110946227A CN 110946227 A CN110946227 A CN 110946227A CN 201911349670 A CN201911349670 A CN 201911349670A CN 110946227 A CN110946227 A CN 110946227A
- Authority
- CN
- China
- Prior art keywords
- powder
- sleep
- improving
- mass
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 48
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 22
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims abstract description 22
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims abstract description 22
- 235000009120 camo Nutrition 0.000 claims abstract description 22
- 235000005607 chanvre indien Nutrition 0.000 claims abstract description 22
- 239000011487 hemp Substances 0.000 claims abstract description 22
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 15
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 15
- 244000197580 Poria cocos Species 0.000 claims abstract description 15
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 15
- 239000011812 mixed powder Substances 0.000 claims abstract description 15
- 241000724115 Ziziphus lotus Species 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 241000218236 Cannabis Species 0.000 claims description 5
- 240000008866 Ziziphus nummularia Species 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 18
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 10
- 206010022437 insomnia Diseases 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 4
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 230000007547 defect Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000006870 function Effects 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000004044 response Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 10
- 230000000147 hypnotic effect Effects 0.000 description 6
- 230000004799 sedative–hypnotic effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229940049706 benzodiazepine Drugs 0.000 description 3
- 239000003326 hypnotic agent Substances 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 206010029412 Nightmare Diseases 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 229940125717 barbiturate Drugs 0.000 description 2
- 150000001557 benzodiazepines Chemical class 0.000 description 2
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 2
- 229960002327 chloral hydrate Drugs 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- ZQDWXGKKHFNSQK-UHFFFAOYSA-N hydroxyzine Chemical compound C1CN(CCOCCO)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZQDWXGKKHFNSQK-UHFFFAOYSA-N 0.000 description 2
- 229960000930 hydroxyzine Drugs 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000004622 sleep time Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100001274 therapeutic index Toxicity 0.000 description 2
- GBBSUAFBMRNDJC-MRXNPFEDSA-N (5R)-zopiclone Chemical compound C1CN(C)CCN1C(=O)O[C@@H]1C2=NC=CN=C2C(=O)N1C1=CC=C(Cl)C=N1 GBBSUAFBMRNDJC-MRXNPFEDSA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- ZKNARUVAUOSLGV-UHFFFAOYSA-N N1N=CC=CC=C1.C1=CC=CC=C1 Chemical compound N1N=CC=CC=C1.C1=CC=CC=C1 ZKNARUVAUOSLGV-UHFFFAOYSA-N 0.000 description 1
- 208000000224 Night Terrors Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- GPWHDDKQSYOYBF-UHFFFAOYSA-N ac1l2u0q Chemical compound Br[Br-]Br GPWHDDKQSYOYBF-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 229940124623 antihistamine drug Drugs 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000008897 memory decline Effects 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229960004010 zaleplon Drugs 0.000 description 1
- HUNXMJYCHXQEGX-UHFFFAOYSA-N zaleplon Chemical compound CCN(C(C)=O)C1=CC=CC(C=2N3N=CC(=C3N=CC=2)C#N)=C1 HUNXMJYCHXQEGX-UHFFFAOYSA-N 0.000 description 1
- 229960001475 zolpidem Drugs 0.000 description 1
- ZAFYATHCZYHLPB-UHFFFAOYSA-N zolpidem Chemical compound N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 ZAFYATHCZYHLPB-UHFFFAOYSA-N 0.000 description 1
- 229960000820 zopiclone Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Botany (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种安眠饮料及其制备方法。本发明属于中药技术领域。本发明解决了现有西医治疗失眠存在的缺陷及中医对失眠的起效慢的技术问题。产品由火麻花和火麻叶的混合粉末、酸枣仁粉末、荷叶粉末、茯苓粉末和火麻仁粉末经混合提取制备而成。本发明的安眠饮料使用方便的袋装方式实现安眠、能够有效缓解人体亚健康状态的优点，操作简单、使用方便，结合临床实践经验，在促进睡眠、提高免疫能力的方面有很好的作用。本发明提供一种安眠饮料的制备方法，采用药食同源原料制备而成，不含西药成分，无毒副作用，长期服用具有安眠和增强免疫力的保健功能。
Description
技术领域
本发明属于中药技术领域，具体涉及一种安眠饮料及其制备方法。
背景技术
失眠通常指患者对睡眠时间和\或质量不满足并影响白天社会功能的一种主观体验。按临床表现分类为：睡眠潜入期：入睡时间超过30分钟；睡眠维持：夜间觉醒次数超过2次或凌晨早醒；睡眠质量：多恶梦；总的睡眠时间少于6小时；日间残留效应：次晨感到头昏，精神不振，嗜睡，乏力等。
按病程分类：一过性或急性失眠，病程小于4周；短期或亚急性失眠，病程大于4周小于3～6个月；长期或慢性失眠，病程大于6个月。按严重程度分类：轻度，偶发，对生活质量影响小；中度，每晚发生，中度影响生活质量，伴一定症状(易怒、焦虑、疲乏等)；重度，每晚发生，严重影响生活质量，临床症状表现突出。
目前常用治疗失眠的药物有镇静催眠药(包括巴比妥类、苯二氮卓类、非典型苯二氮卓类)、抗抑郁药、抗组胺药(目前极少用于催眠)和中药。
第一代镇静催眠药物包括巴比妥类、水合氯醛、三溴合剂和羟嗪(安泰乐)等；它们的治疗指数较低，需中等剂量才改善睡眠,药物之间相互影响比较大、大剂量可影响呼吸。其中羟嗪对有自主神经功能紊乱的患者较合适；水合氯醛因药物之间的相互作用少，广泛用于药物临床试验与不合作者进行某些特殊检查时的快速催眠；苯巴比妥可对苯二氮卓类与其他催眠药进行替代与递减治疗，也可用于儿童睡行症、睡惊症和梦魇等疾病，或者用于拮抗麻黄素、苯丙胺、氨茶碱等药物的中枢兴奋不良反应。
第二代镇静催眠药物主要是指苯二氮卓类镇静催眠药。该类药物是临床上最常用的一种镇静、催眠和抗焦虑药。这些安眠药的特点是治疗指数高、对内脏毒性低和使用安全。缺点是半衰期短，用药后易产生清晨失眠和白天焦虑。
第三代镇静催眠药物主要包括唑吡坦、扎来普隆、佐匹克隆。有一些镇静催眠药安全性高。安眠药吃多了，会引发记忆力衰退，甚至老年痴呆。
发明内容
本发明解决了现有西医治疗失眠存在的缺陷及中医对失眠的起效慢的技术问题，而提供了一种安眠饮料及其制备方法。
本发明的一种安眠饮料按质量份数由火麻花和火麻叶的混合粉末6.5～7.5份、酸枣仁粉末2～3份、荷叶粉末1～2份、茯苓粉末2.5～2.8份和火麻仁粉末3～5份制备而成。
进一步限定，该安眠饮料按质量份数由火麻花和火麻叶的混合粉末7份、酸枣仁粉末2.5份、荷叶粉末1.5份、茯苓粉末2.6份和火麻仁粉末4份制备而成。
制备本发明的一种安眠饮料的方法按以下步骤进行：
一、将火麻花和火麻叶的混合物、酸枣仁、荷叶、茯苓和火麻仁分别用粉碎机粉碎至粒径为200nm～300nm，分别得到火麻花和火麻叶的混合粉末、酸枣仁粉末、荷叶粉末、茯苓粉末和火麻仁粉末；
二、将步骤一得到的火麻花和火麻叶的混合粉末、酸枣仁粉末和荷叶粉末混合后，用乙醇在温度为38～42℃、压力为0.2Mpa～0.3Mpa的条件下进行提取，提取时间为30min～40min，得到提取液；
三、向步骤二得到的提取物中加入茯苓粉末和火麻仁粉末，混合均匀，得到安眠饮料。
进一步限定，步骤一中用粉碎机粉碎至粒径为280nm。
进一步限定，步骤二中所述提取时间为36min。
进一步限定，步骤二中所述温度为41℃。
进一步限定，步骤二中所述压力为0.28Mpa。
本发明的安眠饮料使用方便的袋装方式实现安眠、能够有效缓解人体亚健康状态的优点，操作简单、使用方便，结合临床实践经验，在促进睡眠、提高免疫能力的方面有很好的作用。
本发明提供一种安眠饮料的制备方法，采用药食同源原料制备而成，不含西药成分，无毒副作用，长期服用具有安眠和增强免疫力的保健功能。
具体实施方式
具体实施方式一：本实施方式中的一种安眠饮料按质量份数由火麻花和火麻叶的混合粉末7份、酸枣仁粉末2.5份、荷叶粉末1.5份、茯苓粉末2.6份和火麻仁粉末4份制备而成。
制备上述安眠饮料的方法按以下步骤进行：
一、将火麻花和火麻叶的混合物、酸枣仁、荷叶、茯苓和火麻仁分别用粉碎机粉碎至粒径为280nm，分别得到火麻花和火麻叶的混合粉末、酸枣仁粉末、荷叶粉末、茯苓粉末和火麻仁粉末；
二、将步骤一得到的火麻花和火麻叶的混合粉末、酸枣仁粉末和荷叶粉末混合后，用乙醇在温度为41℃、压力为0.28Mpa的条件下进行提取，提取时间为36min，得到提取液；
三、向步骤二得到的提取物中加入茯苓粉末和火麻仁粉末，混合均匀，得到安眠饮料。
Claims (7)
1.一种安眠饮料，其特征在于，该安眠饮料按质量份数由火麻花和火麻叶的混合粉末6.5～7.5份、酸枣仁粉末2～3份、荷叶粉末1～2份、茯苓粉末2.5～2.8份和火麻仁粉末3～5份制备而成。
2.根据权利要求1所述的一种安眠饮料，其特征在于，该安眠饮料按质量份数由火麻花和火麻叶的混合粉末7份、酸枣仁粉末2.5份、荷叶粉末1.5份、茯苓粉末2.6份和火麻仁粉末4份制备而成。
3.如权利要求1～2任意一项权利要求所述的一种安眠饮料的制备方法，其特征在于，该制备方法按以下步骤进行：
一、将火麻花和火麻叶的混合物、酸枣仁、荷叶、茯苓和火麻仁分别用粉碎机粉碎至粒径为200nm～300nm，分别得到火麻花和火麻叶的混合粉末、酸枣仁粉末、荷叶粉末、茯苓粉末和火麻仁粉末；
二、将步骤一得到的火麻花和火麻叶的混合粉末、酸枣仁粉末和荷叶粉末混合后，用乙醇在温度为38～42℃、压力为0.2Mpa～0.3Mpa的条件下进行提取，提取时间为30min～40min，得到提取液；
三、向步骤二得到的提取物中加入茯苓粉末和火麻仁粉末，混合均匀，得到安眠饮料。
4.根据权利要求3所述的一种安眠饮料的制备方法，其特征在于，步骤一中用粉碎机粉碎至粒径为280nm。
5.根据权利要求3所述的一种安眠饮料的制备方法，其特征在于，步骤二中所述提取时间为36min。
6.根据权利要求3所述的一种安眠饮料的制备方法，其特征在于，步骤二中所述温度为41℃。
7.根据权利要求3所述的一种安眠饮料的制备方法，其特征在于，步骤二中所述压力为0.28Mpa。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911349670.3A CN110946227A (zh) | 2019-12-24 | 2019-12-24 | 一种安眠饮料及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911349670.3A CN110946227A (zh) | 2019-12-24 | 2019-12-24 | 一种安眠饮料及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110946227A true CN110946227A (zh) | 2020-04-03 |
Family
ID=69984036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911349670.3A Pending CN110946227A (zh) | 2019-12-24 | 2019-12-24 | 一种安眠饮料及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110946227A (zh) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106075339A (zh) * | 2016-07-09 | 2016-11-09 | 信阳农林学院 | 一种安眠茶 |
| CN106889393A (zh) * | 2015-12-21 | 2017-06-27 | 北京华昱安然医药科技有限公司 | 一种火麻仁蛋白功能饮料及其制备方法 |
| CN106912765A (zh) * | 2017-02-10 | 2017-07-04 | 天津金匮堂生物科技有限公司 | 一种安神助眠固体饮料及其制备方法 |
| CN107050142A (zh) * | 2017-01-23 | 2017-08-18 | 成都中医药大学 | 一种改善睡眠的中药组合物 |
| CN107439861A (zh) * | 2017-08-11 | 2017-12-08 | 晋城市伊健食品有限公司 | 一种有助于睡眠的食疗饮品及其制备方法 |
| CN107647258A (zh) * | 2017-09-30 | 2018-02-02 | 广西巴马正中长寿食品有限公司 | 一种火麻糊及其制备方法 |
| CN107874241A (zh) * | 2017-10-25 | 2018-04-06 | 宁国平衡健康管理有限公司 | 一种改善睡眠的保健食品及其制备方法 |
| CN108936172A (zh) * | 2018-06-05 | 2018-12-07 | 深圳市持志科技有限公司 | 一种调节孕期睡眠质量的固体饮料及其制备方法 |
| CN110269171A (zh) * | 2018-03-14 | 2019-09-24 | 汉义生物科技（北京）有限公司 | 一种含有火麻仁提取物的饮料及其在改善睡眠中的应用 |
-
2019
- 2019-12-24 CN CN201911349670.3A patent/CN110946227A/zh active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106889393A (zh) * | 2015-12-21 | 2017-06-27 | 北京华昱安然医药科技有限公司 | 一种火麻仁蛋白功能饮料及其制备方法 |
| CN106075339A (zh) * | 2016-07-09 | 2016-11-09 | 信阳农林学院 | 一种安眠茶 |
| CN107050142A (zh) * | 2017-01-23 | 2017-08-18 | 成都中医药大学 | 一种改善睡眠的中药组合物 |
| CN106912765A (zh) * | 2017-02-10 | 2017-07-04 | 天津金匮堂生物科技有限公司 | 一种安神助眠固体饮料及其制备方法 |
| CN107439861A (zh) * | 2017-08-11 | 2017-12-08 | 晋城市伊健食品有限公司 | 一种有助于睡眠的食疗饮品及其制备方法 |
| CN107647258A (zh) * | 2017-09-30 | 2018-02-02 | 广西巴马正中长寿食品有限公司 | 一种火麻糊及其制备方法 |
| CN107874241A (zh) * | 2017-10-25 | 2018-04-06 | 宁国平衡健康管理有限公司 | 一种改善睡眠的保健食品及其制备方法 |
| CN110269171A (zh) * | 2018-03-14 | 2019-09-24 | 汉义生物科技（北京）有限公司 | 一种含有火麻仁提取物的饮料及其在改善睡眠中的应用 |
| CN108936172A (zh) * | 2018-06-05 | 2018-12-07 | 深圳市持志科技有限公司 | 一种调节孕期睡眠质量的固体饮料及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 高哲等: "火麻资源综合加工及产品开发研究进展", 《中国粮油学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101032560B (zh) | 一种治疗睡眠障碍的中药组合物及制备方法 | |
| CN105725211A (zh) | 一种用于改善睡眠的食品保健品及其制备方法 | |
| CN111135285A (zh) | 火麻仁安神助眠组合物及其制备方法和应用 | |
| KR102121153B1 (ko) | 체중감량용 한약 조성물, 이를 포함하는 체중감량용 한약환 및 이의 제조방법 | |
| CN104173493A (zh) | 一种具有改善睡眠作用的药物组合物及其制备方法与应用 | |
| CN102727706A (zh) | 预防和治疗糖尿病的组合物 | |
| CN112294924A (zh) | 一种养心安神药物组合物及其制备方法和应用 | |
| CN104222861A (zh) | 一种治疗失眠的安神保健粥 | |
| CN105267723B (zh) | 一种具有改善睡眠功效的玛咖组方及其制备方法 | |
| CN110946227A (zh) | 一种安眠饮料及其制备方法 | |
| CN106924388A (zh) | 一种治疗失眠的药物组合物及其制备方法、制剂与应用 | |
| CN101940770B (zh) | 一种治疗失眠的药物及其制备方法 | |
| CN104706881A (zh) | 一种具有调节睡眠功能的保健品 | |
| CN109464527B (zh) | 组合物及其制备方法和应用、保健品和改善睡眠的药物 | |
| CN113599466A (zh) | 一种具有安神助眠功能的植物提取物 | |
| CN102631482A (zh) | 一种具有防治糖尿病及并发症的中药组合物 | |
| CN112603948A (zh) | 一种治疗失眠症的药物及其制备方法 | |
| CN105770482A (zh) | 一种具有改善睡眠作用的外用组合物及其制备方法 | |
| CN111568963A (zh) | 一种可改善睡眠的保健胶囊的制备方法 | |
| CN109432220A (zh) | 参枣促眠片及其制备方法 | |
| CN109248275A (zh) | 一种具有改善睡眠作用的药物组合物及其制备方法和作用 | |
| CN108743791A (zh) | 一种镇静催眠的中药组合物 | |
| CN117159658B (zh) | 一种预防、减缓或治疗顽固性失眠的中药组合物及制作工艺 | |
| CN108653457B (zh) | 一种治疗小儿疳积的中药组合物 | |
| CN101695522A (zh) | 一种治疗失眠的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200403 |
|
| RJ01 | Rejection of invention patent application after publication |